1. Home
  2. Publications
  1. Home
  2. Publications

Filters

Research Groups

Core Facilities


Start date
End date

Abstract A094: Mapping early Pancreatic Cancer evolution through enhancer reprogramming and transcription factor interactomes

Authors: PD Santos, L Young, S Baloul, C Simpson, C Graewe, K Kishore, T Halim, A Ru...
Research group: Carroll Group
E-pub date: 25 Sep 2026
Journal name: Cancer Research

Nature-Inspired Histidine and Guanidine Modification of Magnetic Nanoparticles for Urinary DNA Liquid Biopsy.

Authors: D Haddad, I Ahmed, M Pitoulias, R Mair, L Fruk
Research group: Mair Group
E-pub date: 18 Sep 2026
Journal name: Small Methods

scFLAME: a unified generative model for interpretable clustering, hierarchical structure discovery and marker-gene identification in single-cell RNA-seq data

Authors: J Rao, M Jihad, G Biffi, PDW Kirk
Research group: Biffi Group
E-pub date: 11 Sep 2026
Journal name:

The transcription factor BACH1 couples chromatin priming and repression to enable macrophage plasticity and adaptation.

Authors: P Tzerpos, D Bojcsuk, K Bene, N Caballero-Sánchez, Z Parteka-Tojek, K Bane...
Research group: Carroll Group
E-pub date: 8 Sep 2026
Journal name: Immunity

Imaging the hallmarks of cancer.

Authors: J Grimm, F Kiessling, KM Brindle, D Hanahan, SK Jain, P Lambin, T Lammers, ...
Research group:
E-pub date: 1 Sep 2026
Journal name: Nat Rev Cancer

Longitudinal transcriptomic profiling identifies predictors of response to neoadjuvant chemoimmunotherapy in triple-negative breast cancer: results from the NeoTRIPaPDL1 trial.

Authors: M Dugo, C-S Huang, D Egle, B Bermejo, RS Seitz, TJ Nielsen, C Zamagni, M Th...
Research group: Ali Group
E-pub date: 1 Sep 2026
Journal name: Ann Oncol

A tumour-derived organoid biobank maps cancer gene dependencies.

Authors: C Herranz-Ors, SG Bhosle, AE Beck, JGR Gilbert, G Picco, J Espejo Valle-Inc...
Research group: Brenton Group
E-pub date: 1 Sep 2026
Journal name: Nature

2O National real-world tumour-normal WGS with target trial emulation identifies DNA repair phenotypes predicting platinum and PARP inhibitor benefit in high-grade ovarian cancers

Authors: IG Funingana, J Ambrose, L Porcu, P Smith, T Bradley, IP Machado, P Tarpey,...
Research group: Markowetz Group, Brenton Group
E-pub date: 1 Sep 2026
Journal name: ESMO Open